Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
30.56
-0.54 (-1.74%)
Feb 20, 2026, 12:31 PM EST - Market open
Viking Therapeutics Employees
Viking Therapeutics had 53 employees as of December 31, 2025. The number of employees increased by 17 or 47.22% compared to the previous year.
Employees
53
Change
17
Growth
47.22%
Revenue / Employee
n/a
Profits / Employee
-$6,785,642
Market Cap
3.53B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| ADMA Biologics | 685 |
| ACADIA Pharmaceuticals | 654 |
| Arcutis Biotherapeutics | 342 |
| Xenon Pharmaceuticals | 327 |
| Alumis | 223 |
| Edgewise Therapeutics | 136 |
| Centessa Pharmaceuticals | 114 |
VKTX News
- 6 days ago - Viking Therapeutics: Full-Speed Ahead - Seeking Alpha
- 7 days ago - Viking Therapeutics: Buyers Are Quietly Accumulating On Its Obesity Drugs Launch Potential - Seeking Alpha
- 8 days ago - Viking Therapeutics, Inc. (VKTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Viking Therapeutics plans to advance oral obesity drug to late-stage trial - Reuters
- 8 days ago - Viking Therapeutics Stock Climbs After Q4 Report: Details - Benzinga
- 8 days ago - Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 14 days ago - The Commoditization Of GLP-1s: Why Viking's Maintenance Hedge Is Falling Short - Seeking Alpha
- 15 days ago - Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026 - PRNewsWire